JP2019504865A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504865A5
JP2019504865A5 JP2018542754A JP2018542754A JP2019504865A5 JP 2019504865 A5 JP2019504865 A5 JP 2019504865A5 JP 2018542754 A JP2018542754 A JP 2018542754A JP 2018542754 A JP2018542754 A JP 2018542754A JP 2019504865 A5 JP2019504865 A5 JP 2019504865A5
Authority
JP
Japan
Prior art keywords
ethanol
room temperature
solution
dihydrophthalazine
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018542754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019504865A (ja
JP6949856B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/000209 external-priority patent/WO2017140422A1/en
Publication of JP2019504865A publication Critical patent/JP2019504865A/ja
Publication of JP2019504865A5 publication Critical patent/JP2019504865A5/ja
Application granted granted Critical
Publication of JP6949856B2 publication Critical patent/JP6949856B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018542754A 2016-02-16 2017-02-15 5−アミノ−2,3−ジヒドロフタラジン−1,4−ジオンの結晶形の製造方法 Active JP6949856B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16000380.2 2016-02-16
EP16000380 2016-02-16
PCT/EP2017/000209 WO2017140422A1 (en) 2016-02-16 2017-02-15 Method for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione

Publications (3)

Publication Number Publication Date
JP2019504865A JP2019504865A (ja) 2019-02-21
JP2019504865A5 true JP2019504865A5 (https=) 2020-03-26
JP6949856B2 JP6949856B2 (ja) 2021-10-13

Family

ID=55361317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018542754A Active JP6949856B2 (ja) 2016-02-16 2017-02-15 5−アミノ−2,3−ジヒドロフタラジン−1,4−ジオンの結晶形の製造方法

Country Status (8)

Country Link
US (1) US11203575B2 (https=)
EP (1) EP3416952B1 (https=)
JP (1) JP6949856B2 (https=)
KR (1) KR102535959B1 (https=)
CN (1) CN109071461B (https=)
CA (1) CA3011766C (https=)
ES (1) ES2796476T3 (https=)
WO (1) WO2017140422A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3511325A1 (en) * 2018-01-11 2019-07-17 MetrioPharm AG Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione
EP3870175B1 (en) * 2018-10-26 2024-08-28 Immunopharma Plus D.O.O. Oral aminodihydrophthalazinedione compositions and their use the treatment of non-viral hepatitis
EP3858328A1 (en) * 2020-01-31 2021-08-04 MetrioPharm AG Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmonary diseases
KR20220158030A (ko) * 2020-03-25 2022-11-29 메트리오팜 아게 급성 폐손상 치료용 5-아미노-2,3-디히드로-1,4-프탈라진디온
MX2022015601A (es) * 2020-06-10 2023-01-30 Metriopharm Ag Compuesto para el tratamiento de infecciones coronavirales.
JP2023553290A (ja) * 2020-12-01 2023-12-21 リバースパ エルエルシー 慢性閉塞性肺疾患、喘息、肺炎、気管支炎、嚢胞性線維症、肺水腫、間質性肺疾患、サルコイドーシス、特発性肺胞線維症、急性呼吸窮迫症候群、および肺動脈性肺高血圧症を治療するための方法および組成物
CN116963738A (zh) * 2020-12-02 2023-10-27 麦翠奥制药公司 用于SARS-CoV-2感染的后遗症的预防和治疗的鲁米诺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743541A (en) * 1985-07-17 1988-05-10 Mast Immunosystems, Inc. Luminescent substrate preparation and its use in specific binding assays
FR2839155B1 (fr) * 2002-04-25 2005-02-04 Roc Imp Procede pour detecter et localiser des traces de sang et compose pour detecter des traces de sang
BRPI0307864B1 (pt) * 2003-11-25 2016-01-12 Univ Rio De Janeiro processo para formação de hidrazidas a partir de hidrazinas e ácido dicarboxílicos
CN100390152C (zh) * 2006-03-23 2008-05-28 潘健 一种合成3-硝基或3-氨基邻苯二甲酰肼的方法
PL231885B1 (pl) * 2009-01-16 2019-04-30 Abidopharma Spolka Z Ograniczona Odpowiedzialnoscia Sposób wytwarzania soli 5-amino-2,3-dihydroftalazyno-1,4-di onu z metalami alkalicznymi, ich kompozycje farmaceutyczne i ich zastosowanie
ES2487221T3 (es) * 2010-03-01 2014-08-20 Metriopharm Ag Formas cristalinas de 5-amino-2,3-dihidroftalazina-1,4-diona sal sódica (sal sódica 5-amino-2,3-dihidroftalazina-1,4-diona), preparados farmacéuticos que la contienen y método de producción
US20110246075A1 (en) * 2010-04-01 2011-10-06 Banik Niranjan C Providing a Transform Function to Produce a Mechanical Property of a Subterranean Structure
WO2011123776A2 (en) * 2010-04-01 2011-10-06 Guthery B Eugene Method for detecting occult blood

Similar Documents

Publication Publication Date Title
JP2019504865A5 (https=)
JP2018024682A5 (https=)
JP2018035160A5 (https=)
JP2015063536A5 (https=)
JP2013049690A5 (https=)
JP2014221842A5 (https=)
JP2009120624A5 (https=)
JP2010533203A5 (https=)
JP2018505199A5 (https=)
JP2018520178A5 (https=)
JP2019504103A5 (https=)
JP2009531465A5 (https=)
JP2019505533A5 (https=)
CN103271210A (zh) 阿胶核枣糕
JP2012176989A5 (https=)
JP2012500819A5 (https=)
RU2016118796A (ru) Новая кристаллическая форма 2-{ 3-[2-(1-{ [3, 5-бис(дифторметил)-1н-пиразол-1-ил]ацетил} пиперидин-4-ил)-1, 3-тиазол-4-ил]-4, 5-дигидро-1, 2-оксазол-5-ил} -3-хлорфенилметансульфоната
JP2018522945A5 (https=)
JP2014520848A5 (https=)
JP2018516946A5 (https=)
CN111386268A (zh) 一种urat1抑制剂的晶型及其制备方法
CN107254055B (zh) 一种直接从等规聚1-丁烯本体中结晶生成i晶的方法
JP2012530118A5 (https=)
JP2013503145A5 (https=)
CN111417633A (zh) 一种β-内酰胺酶抑制剂的晶型及其制备方法